[1]郭睿,金雪媛,田怡,等.地尔硫卓上调异黏蛋白在肝癌细胞中的表达[J].南方医科大学学报,2019,(03):298.
点击复制

地尔硫卓上调异黏蛋白在肝癌细胞中的表达()
分享到:

《南方医科大学学报》[ISSN:1673-4254/CN:44-1627/R]

卷:
期数:
2019年03期
页码:
298
栏目:
出版日期:
2019-04-11

文章信息/Info

Title:
Calcium channel blocker diltizem transiently inhibits migration and up-regulates metadherin expression in hepatocellular carcinoma cells in vitro
作者:
郭睿金雪媛田怡黄小钟李宗芳杨军
关键词:
肝细胞癌多药耐药钙离子抑制剂地尔硫卓异黏蛋白
Keywords:
hepatocellular carcinoma multi-drug resistance diltizem metadherin calcium channel blockers
摘要:
目的研究钙离子通道抑制剂逆转肝癌细胞多药耐药和对异黏蛋白表达的影响及分子机制。方法采用不同浓度钙离子 抑制剂(0、25、50、100、200、400 μmol/L)干预肝癌MHCC97H、7402细胞不同时间(12、24、48 h)后,用体外细胞划痕实验检测处 理后肝癌细胞运动迁徙能力;采用RT-PCR和免疫细胞化学技术检测钙离子抑制剂对肝癌细胞中P-gp和异黏蛋白的表达的影 响。结果钙离子抑制剂能够一过性抑制肝癌MHCC97H、7402 细胞的迁徙运动能力,且具有一定的时间和浓度依赖性特点 (P<0.05)。同时,不同浓度钙离子抑制剂盐酸地尔硫卓均能一过性上调肝癌MHCC97H、7402细胞中异黏蛋白mRNA和蛋白的 表达(P<0.05),但并不抑制P-gp蛋白的表达。结论钙离子抑制剂地尔硫卓能一过性抑制MHCC97H、7402肝癌细胞的迁徙运 动,并能反馈性上调促癌基因异黏蛋白mRNA和蛋白的表达水平。因而,采用钙离子抑制剂很可能具有增加肿瘤进展的潜在风险。
Abstract:
Objective To investigate the effect of calcium channel blocker diltizem in reversing multi-drug resistance (MDR) and on metadherin expression in hepatocellular carcinoma cells and explore the molecular mechanism. Methods Hepatocellular carcinoma MHCC97H and 7402 cells were treated with diltiazem hydrochloride, a calcium channel blocker (0, 25, 50, 100, 200, and 400 μmol/L), for 12, 24, or 48 h. Wound healing assay was employed to assess the changes in the mobility and migration of the cells following the treatments, and the changes in the expression levels of metadherin mRNA and protein and P-gp protein were determined using RT-PCR and immunocytochemistry. Results Diltiazem hydrochloride could transiently inhibit the migration and movement of MHCC97H and 7402 cells in vitro in a time- and concentration-dependent manner (P<0.05). Diltiazem hydrochloride at different concentrations also transiently up-regulated the expressions of metadherin mRNA and protein but did not inhibit the expression of P-gp protein in MHCC97H and 7402 cells. Conclusion Calcium channel blocker can transiently inhibit the migration of hepatocellular carcinoma cells in vitro and up-regulate the expression of metadherin mRNA and protein through a feedback mechanism, suggesting the potential risk of calcium channel blockers for promoting tumor progression during the treatment of malignant tumors.

相似文献/References:

[1]李湘竑,钟克波,刘延,等.索拉菲尼治疗肝癌肝移植术后肿瘤复发患者的疗效及安全性分析[J].南方医科大学学报,2011,(09):1608.
[2]郭丹,陈娜娜,侯连兵,等.前列腺素E2活化EP2受体促进肝癌细胞增殖[J].南方医科大学学报,2011,(09):1564.
[3]熊新,周远大.蟾酥注射液逆转HL60/阿霉素细胞多药耐药的机制[J].南方医科大学学报,2012,(03):337.
[4]陈可和,梁博,邹镇洪,等.Rheb和Rheb’D60K突变基因重组慢病毒载体的构建、鉴定及其对肝癌细胞凋亡的影响[J].南方医科大学学报,2012,(03):341.
[5]赵爱国,吴曙光.沉默CDK7基因对HepG2细胞株的抗增殖作用[J].南方医科大学学报,2005,(01):58.
 ZHAO Ai-guo,WU Shu-guang.Effect of CDK7 gene silencing against hepatoblastoma HepG2 cell proliferation[J].Journal of Southern Medical University,2005,(03):58.
[6]金吴东,陈龙华,穆峰.外源性mTκα基因抑制肝癌细胞HepG2的生长[J].南方医科大学学报,2004,(10):1133.
 JIN Wu-dong,CHEN Long-hua,MU Feng.Exogenous mTκα gene inhibits the growth of HepG2 heptocellular carcinoma cells[J].Journal of Southern Medical University,2004,(03):1133.
[7]余元龙,季明芳,何洁冰,等.紫杉醇、5-氟脲嘧啶抑制肝癌细胞BEL-7402生长和诱导凋亡的比较[J].南方医科大学学报,2005,(07):864.
 YU Yuan-long,JI Ming-fang,HE Jie-bing,et al.Effects of paclitaxel and 5-fluorouracil on growth inhibition and apoptosis of hepatoma cells:a comparative study[J].Journal of Southern Medical University,2005,(03):864.
[8]袁亚维,孙爱民,李传刚.KBV200细胞多药耐药与蛋白激酶C表达上调的关系[J].南方医科大学学报,2005,(11):1341.
 YUAN Ya-wei,SUN Ai-min,LI Chuan-gang.Correlation of multidrug resistance with up-regulation of protein kinase C expression in KBV200 cells[J].Journal of Southern Medical University,2005,(03):1341.
[9]陈志丰,梁宏,张祥松,等.肝癌治疗后甲胎蛋白增高患者的18F-FDG PET/CT与增强CT对照研究[J].南方医科大学学报,2012,(11):1615.
[10]杨国华,薛芳沁,陈晓耕.不同分子分型乳腺癌干细胞MDR1表达的研究[J].南方医科大学学报,2012,(11):1636.

更新日期/Last Update: 1900-01-01